Background
The spine was one of the most common sites of bone metastasis. The number of patients with spinal metastasis remarkably increased due to the large number of patients and survival [ 1 ]. Bone protectants such as denosumab and zoledronic acid had significantly reduced the incidence of skeletal-related events [ 2 , 3 ]. However, surgery was still the first choice for patients with pathological fractures, spinal cord, or nerve root compression to improve patients’ symptoms and quality of life rapidly.
For most patients with spinal metastases, the surgery aimed to improve the quality of life rather than radically remove local lesions. Conventional surgery was effective for symptomatic spinal metastases accompanied by higher postoperative complications [ 4 , 5 ]. Rapid rehabilitation and high quality of life were essential for subsequent treatment, such as radiation, chemotherapy, or targeted drugs for patients with advanced cancer.
More spinal tumor surgeons performed minimally invasive surgical methods for patients with spinal metastases. The core purpose of minimally invasive treatment was to reduce muscle tissue peeling. Pedicle screws were percutaneously placed under fluoroscopy or freehand pedicle screw fixation. Decompression was mainly performed using small incision [ 6 – 8 ] and trans-tubular [ 9 – 11 ]. These two minimally invasive surgical methods had achieved positive therapeutic results in clinical practice. However, there was no literature to compare these two minimally invasive methods. In clinical work, it needed to be clarified how to choose between these two methods. The present study compared the effectiveness and safety of these minimally invasive surgeries (mini-open and trans-tubular). The results would guide surgeons in selecting the appropriate method.
Methods
Study design and selection criteria
This was a single-centered retrospective cohort study of patients with spinal metastases who underwent decompression surgery through a mini-open or trans-tubular approach in our department from June 2017 to June 2022. Patients were assigned to two groups according to the decompression approach: The mini-open approach and the Trans-tubular approach.
Exclusion criteria:
Patients with recurrent tumors; Patients who simultaneously underwent conventional decompression surgery at the same or different segment;
Data collection
We reviewed the medical records to assess general, operational, laboratory, and functional data among the clinical variables. General data included age, gender, ASA (American Society of Anesthesiologists physical status classification system), tumor pathology, clinical manifestation, and Tokuhashi score. Laboratory data included preoperative and postoperative HGB, HCT, and ALB. Operation-related data included the blood loss, the location, and number of decompression segments, decompression approach, operation time, blood transfusion on an operative day, drainage amount, complications, and postoperative hospitalization. According to AIS, functional status data included the Visual Analogue Scale (VAS), Karnofsky score, ambulatory status, and neurological function. Metastasis from renal, liver, and thyroid tumors was assigned to the hyper-vascular tumor [ 12 ].
Surgical procedure
An experienced spinal tumor surgeon under general anesthesia performed all surgeries. Pedicle screws were percutaneously placed under fluoroscopy or freehand pedicle screw fixation [ 13 ]. Circum-spinal decompression was achieved through the trans-tubular approach and the Mini-open approach. The trans-tubular approach was performed through a unilateral paraspinal muscle space [ 10 ]. The operation was performed through a unilateral paravertebral muscular space approach with an expandable tubular retractor and a cold light source. This approach could preserve the integrity of the bony structures, including the spinous process, the contralateral vertebral plate, and the lesser articulations, and protect the attachment of the paravertebral musculature. Before placing the tubular retractor, the pedicles of the diseased vertebrae were precisely localized with a K-wire. Depending on the degree of obesity, a longitudinal incision was made 2 cm or more lateral to the skin projection of the pedicle. After the incision of the deep fascia, the paravertebral muscles were bluntly separated, and a tubular retractor was placed. Appropriate muscle stripping revealed the diseased vertebrae’s transverse processes and small joints. If the transverse processes, small joints, and pedicles were not involved with the tumor, those were removed in pieces to expose the tumor. Spatula and osteotome were used to remove the tumor in the vertebral body carefully, and the tumor protruded into the vertebral canal behind the vertebral body by piecemeal excision. If the small joints and the transverse processes were involved, the transverse processes, small joints, and part of the pedicles that the tumor had invaded could be resected directly, the nerve roots should be exposed and protected, and the lateral side of the dural sac should be exposed. The mini-open approach was only through a small skin incision at the decompression segment [ 8 ]. The mini-open approach was performed via the median posterior approach only at the decompression segment. The deep fascia was cut longitudinal along the incision. Sacrospinalis muscles were stripped from the bone surface to expose the posterior structures. The posterior structures and pedicles of the vertebra were removed by piecemeal excision to expose the dural sac and tumor. Spatula and osteotome were used to carefully remove the pedicle tumor, the vertebral body, and the tumor protruding into the vertebral canal behind the vertebral body by piecemeal excision. The nerve root should be exposed and protected.
Outcome measurement
The primary outcome was total blood loss. The Gross equation calculated the total blood loss [ 14 ].
Gross equation: total perioperative blood loss = theoretical total blood loss + allogeneic blood transfusion. Patients in this study did not use autologous blood transfusions during and after surgery.
Theoretical total blood loss = estimated blood volume × 2 × (preoperative Hct-postoperative Hct) / (preoperative Hct + postoperative Hct). Postoperative Hct was examined on the first morning after the operation.
Patient’s estimated blood volume = k1×height (m)³+k2×weight (kg) + k3 [ 15 ].
Male patients k1 = 0.3669, k2 = 0.03219, k3 = 0.6041; Female patients k1 = 0.3561, k2 = 0.03308, k3 = 0.1833.
Other perioperative data were set as secondary outcomes.
the amount of intraoperative blood transfusion. the amount and time of drainage. the length of postoperative hospitalization. intraoperative complication (dural tear). the improvement of functional status.
The intraoperative indication for transfusion in our hospital was HGB less than 80 g/L in general or 90 g/L for patients with coronary heart disease.
Statistical analysis
Continuous variables were presented as mean ± SE. Categorical variables were expressed as numbers. Independent sample t-test was used to detect the difference among continuous variables. The differences among the categorical variables were analyzed using the chi-square test or Fisher’s Exact Test (n < 40). All tests were on 2 sides. A p-value < 0.05 was considered statistically significant. Patients with missing data related to primary outcomes were excluded from the study. Delete cases with missing data of other values during the statistical process. Delete cases with missing values during the statistical process. Data were analyzed with SPSS 25.0 statistical software (IBM Corporation, Armonk, NY.).
Results
Patient enrollment
Thirty-seven consecutive patients were enrolled as our initial cases. We excluded those patients with recurrent tumors (1 case) and simultaneous conventional decompression surgery (2 cases). At last, a total of 34 patients were included in this study. Nineteen patients underwent decompression surgery through the Mini-open approach, and 15 patients underwent decompression surgery through the Trans-tubular approach. The flow of patient enrolment is shown in Fig. 1 .
Fig. 1 The flowchart of patient inclusion

Patient’s baseline data
The study included 34 patients with a mean age of 66.0 ± 1.9 years. There were 25 males and nine females. The detailed baseline data were shown in Tables 1 and 2 , and Table 3 . Except for Ambulatory status, there were no significant differences between the Trans-tubular and Mini-open groups’ demographic, preoperative tumor-related data, functional status, and laboratory data. The trans-tubular group had more patients who could walk (80% vs. 52.6%, P <0.001) than the Mini-open group.
Table 1 Baseline data Characteristic MO (n = 19) TA (n = 15) P Age 66.4 ± 2.2 65.4 ± 3.3 0.792 Gender Female 4 5 0.462 Male 15 10 ASA score II 8 10 0.185 III 11 5 Tumor pathology Renal 2 4 0.331 Lung 5 4 Prostate 8 2 Multiple myeloma 1 3 Uroepithelium 1 1 Esophageal 0 1 Colon 1 0 Breast 1 0 Blood supply Hypervascular (renal) 2 4 0.370 Non-hyper vascular (non-renal) 17 11 Clinical manifestation Spinal nerve root symptom 15 14 0.355 Spinal cord symptom 4 1 Tokuhashi score 7.7 ± 0.5 7.5 ± 0.6 0.784
Table 1
Baseline data
| Characteristic | MO (n = 19) | TA (n = 15) | P |
| Age | 66.4 ± 2.2 | 65.4 ± 3.3 | 0.792 |
| Gender | |||
| Female | 4 | 5 | 0.462 |
| Male | 15 | 10 | |
| ASA score | |||
| II | 8 | 10 | 0.185 |
| III | 11 | 5 | |
| Tumor pathology | |||
| Renal | 2 | 4 | 0.331 |
| Lung | 5 | 4 | |
| Prostate | 8 | 2 | |
| Multiple myeloma | 1 | 3 | |
| Uroepithelium | 1 | 1 | |
| Esophageal | 0 | 1 | |
| Colon | 1 | 0 | |
| Breast | 1 | 0 | |
| Blood supply | |||
| Hypervascular (renal) | 2 | 4 | 0.370 |
| Non-hyper vascular (non-renal) | 17 | 11 | |
| Clinical manifestation | |||
| Spinal nerve root symptom | 15 | 14 | 0.355 |
| Spinal cord symptom | 4 | 1 | |
| Tokuhashi score | 7.7 ± 0.5 | 7.5 ± 0.6 | 0.784 |
Table 2 Laboratory data Characteristic MO (n = 19) TA (n = 15) P Pre-operation HGB (g/L) 120.5 ± 3.5 120.1 ± 5.6 0.951 Hct (%) 35.9 ± 1.1 36.2 ± 1.8 0.907 Alb (g/L) 39.1 ± 0.9 37.9 ± 1.2 0.447 Decline (Postoperative day 1) HGB decline (g/L) 20.8 ± 2.0 17.4 ± 4.3 0.481 Hct decline (%) 6.5 ± 0.6 5.6 ± 1.3 0.537 Alb decline (g/L) 7.8 ± 0.7 6.7 ± 1.1 0.401 HGB, haemoglobin; Hct, haematocrit; Alb, albumin
Table 2
Laboratory data
HGB, haemoglobin; Hct, haematocrit; Alb, albumin
| Characteristic | MO (n = 19) | TA (n = 15) | P |
| Pre-operation | |||
| HGB (g/L) | 120.5 ± 3.5 | 120.1 ± 5.6 | 0.951 |
| Hct (%) | 35.9 ± 1.1 | 36.2 ± 1.8 | 0.907 |
| Alb (g/L) | 39.1 ± 0.9 | 37.9 ± 1.2 | 0.447 |
| Decline (Postoperative day 1) | |||
| HGB decline (g/L) | 20.8 ± 2.0 | 17.4 ± 4.3 | 0.481 |
| Hct decline (%) | 6.5 ± 0.6 | 5.6 ± 1.3 | 0.537 |
| Alb decline (g/L) | 7.8 ± 0.7 | 6.7 ± 1.1 | 0.401 |
Table 3 Functional status Characteristic MO (n = 19) TA (n = 15) P Pre-operation VAS 7.7 ± 0.2 7.9 ± 0.1 0.573 Karnofsky score 56.8 ± 1.7 58.7 ± 1.7 0.458 Ambulatory status Nonambulatory 9 3 <0.001 Ambulatory (assistant) 10 3 Ambulatory 0 9 AIS C 1 0 0.215 D 2 2 E 1 5 Post-operation improvement VAS 2.9 ± 0.2 2.9 ± 0.4 0.927 Karnofsky score 61.6 ± 1.4 64.8 ± 4.8 0.485 Ambulatory status Improve 14 5 0.036 Same 5 10 Aggravate 0 0 AIS Improve 1 5 0.242 Same 3 2 Aggravate 0 0 AIS, American Spinal Injury Association Impairment Scale; VAS, Visual Analogue Scale
Table 3
Functional status
AIS, American Spinal Injury Association Impairment Scale; VAS, Visual Analogue Scale
| Characteristic | MO (n = 19) | TA (n = 15) | P |
| Pre-operation | |||
| VAS | 7.7 ± 0.2 | 7.9 ± 0.1 | 0.573 |
| Karnofsky score | 56.8 ± 1.7 | 58.7 ± 1.7 | 0.458 |
| Ambulatory status | |||
| Nonambulatory | 9 | 3 | <0.001 |
| Ambulatory (assistant) | 10 | 3 | |
| Ambulatory | 0 | 9 | |
| AIS | |||
| C | 1 | 0 | 0.215 |
| D | 2 | 2 | |
| E | 1 | 5 | |
| Post-operation improvement | |||
| VAS | 2.9 ± 0.2 | 2.9 ± 0.4 | 0.927 |
| Karnofsky score | 61.6 ± 1.4 | 64.8 ± 4.8 | 0.485 |
| Ambulatory status | |||
| Improve | 14 | 5 | 0.036 |
| Same | 5 | 10 | |
| Aggravate | 0 | 0 | |
| AIS | |||
| Improve | 1 | 5 | 0.242 |
| Same | 3 | 2 | |
| Aggravate | 0 | 0 |
Primary outcome
The surgical outcomes were shown in Table 4 . There were no significant differences in the incidence of preoperative arterial embolism, the location of the lesion, and the number of decompression segments between the Trans-tubular and Mini-open groups. Although it did not reach a statistically significant level, the Trans-tubular group had less blood loss than the Mini-open group (1192.3 ± 183.2 ml vs. 1571.9 ± 97.4 ml, P = 0.061). We also conducted a sub-group analysis to clarify the relevance of the tumor’s vascular supply to the blood loss of the two groups (Table 5 ). For patients with hyper-vascular tumor (renal), the Trans-tubular group had more blood loss than the Mini-open group (1855.6 ± 342.4 ml vs. 1340.8 ± 203.2 ml, P = 0.385). For patients with hypo-vascular tumors, the Trans-tubular group had significantly less blood loss than the Mini-open group (951.1 ± 171.7 ml vs. 1599.1 ± 105.7 ml, P = 0.026).
Table 4 Surgical data Characteristic MO (n = 19) TA (n = 15) P Location of the lesion Lumbar spine 15 8 0.151 Thoracic spine 4 7 Number of decompression segment 1 15 14 0.355 2 4 1 Preoperative embolism Yes 2 2 1.000 No 17 13 Dural tear Yes 0 2 0.187 No 19 13 Operative time (min) 278.7 ± 9.6 254.5 ± 16.6 0.194 Blood loss(ml): Gross equation 1571.9 ± 97.4 1192.3 ± 183.2 0.061 Intraoperative blood transfusion (ml) 673.7 ± 68.8 480.0 ± 97.2 0.104 Drainage: Amount (ml) 364.5 ± 64.2 133.5 ± 30.9 0.003 Drainage: Time (day) 4.6 ± 0.5 3.1 ± 0.2 0.019 Postoperative hospitalization (day) 10.3 ± 2.4 9.0 ± 0.9 0.640 Note: Two patients in TA group with dural injury were excluded when calculating the drainage volume
Table 4
Surgical data
Note: Two patients in TA group with dural injury were excluded when calculating the drainage volume
| Characteristic | MO (n = 19) | TA (n = 15) | P |
| Location of the lesion | |||
| Lumbar spine | 15 | 8 | 0.151 |
| Thoracic spine | 4 | 7 | |
| Number of decompression segment | |||
| 1 | 15 | 14 | 0.355 |
| 2 | 4 | 1 | |
| Preoperative embolism | |||
| Yes | 2 | 2 | 1.000 |
| No | 17 | 13 | |
| Dural tear | |||
| Yes | 0 | 2 | 0.187 |
| No | 19 | 13 | |
| Operative time (min) | 278.7 ± 9.6 | 254.5 ± 16.6 | 0.194 |
| Blood loss(ml): Gross equation | 1571.9 ± 97.4 | 1192.3 ± 183.2 | 0.061 |
| Intraoperative blood transfusion (ml) | 673.7 ± 68.8 | 480.0 ± 97.2 | 0.104 |
| Drainage: Amount (ml) | 364.5 ± 64.2 | 133.5 ± 30.9 | 0.003 |
| Drainage: Time (day) | 4.6 ± 0.5 | 3.1 ± 0.2 | 0.019 |
| Postoperative hospitalization (day) | 10.3 ± 2.4 | 9.0 ± 0.9 | 0.640 |
Table 5 Sub-analysis of surgical data Characteristic Hyper-vascular tumor (renal) Hypo-vascular tumor (non-renal) MO (n = 2) TA (n = 4) P MO (n = 17) TA (n = 11) P Operation time (min) 308.5 ± 5.5 315.8 ± 40.8 0.911 275.2 ± 10.4 232.3 ± 12.5 0.015 Blood loss(ml): Gross equation 1340.8 ± 203.2 1855.6 ± 342.4 0.385 1599.1 ± 105.7 951.1 ± 171.7 0.026 Intraoperative Blood transfusion (ml) 600.0 ± 200.0 700.0 ± 251.6 0.813 682.3 ± 74.9 400.0 ± 93.4 0.002
Table 5
Sub-analysis of surgical data
| Characteristic | Hyper-vascular tumor (renal) | Hypo-vascular tumor (non-renal) | ||||
| MO (n = 2) | TA (n = 4) | P | MO (n = 17) | TA (n = 11) | P | |
| Operation time (min) | 308.5 ± 5.5 | 315.8 ± 40.8 | 0.911 | 275.2 ± 10.4 | 232.3 ± 12.5 | 0.015 |
| Blood loss(ml): Gross equation | 1340.8 ± 203.2 | 1855.6 ± 342.4 | 0.385 | 1599.1 ± 105.7 | 951.1 ± 171.7 | 0.026 |
| Intraoperative Blood transfusion (ml) | 600.0 ± 200.0 | 700.0 ± 251.6 | 0.813 | 682.3 ± 74.9 | 400.0 ± 93.4 | 0.002 |
Secondary outcomes
There were no significant differences in the operative time, intraoperative blood transfusion, intraoperative complication (dural tear), and postoperative hospitalization between the Trans-tubular and Mini-open groups (Table 4 ). The trans-tubular group had significantly less amount of postoperative drainage (133.5 ± 30.9 ml vs. 364.5 ± 64.2 ml, p = 0.003), and the time of drainage (3.1 ± 0.2 days vs. 4.6 ± 0.5 days, p = 0.019) compared with Mini-open group. For patients with hyper-vascular tumors (renal), the operation time and intraoperative blood transfusion were comparable between the two groups. For patients with hypo-vascular tumors, patients in the Trans-tubular group had significantly less operation time (232.3 ± 12.5 min vs. 275.2 ± 10.4 min, P = 0.015) and intraoperative blood transfusion (400.0 ± 93.4 ml vs. 682.3 ± 74.9 ml, P = 0.002) compared with patients in Mini-open group (Table 5 ). There were no significant differences in HGB, Hct, and Alb between the two groups on postoperative day 1. However, HGB, Hct, and Alb declined more in the Mino-open group. Except for Ambulatory status, there were no significant differences in the functional improvement of AIS, VAS, and Karnofsky scores between the two groups. The mini-open group had better improvement in Ambulatory status than the Trans-tubular group (73.7% vs. 33.3%, P <0.036).
Discussion
More and more spinal tumor surgeons use minimally invasive methods to treat metastatic spinal tumors. Minimally invasive surgery can achieve the same therapeutic effect regarding safety, pain reduction, and neurological outcome compared to conventional surgery [ 16 ]. The present study comprehensively analyzes the two main minimally invasive surgery methods: mini-open and trans-tubular. This study showed that both mini-open and trans-tubular surgery were effective and safe for patients with spinal metastases.
The gross equation was used to calculate the perioperative blood loss. This study showed that the trans-tubular group had less blood loss, intraoperative allogeneic blood transfusion, and operation time than the mini-open group for non-hypervascular tumors. Conversely, the trans-tubular group had more blood loss, intraoperative allogeneic blood transfusion, and operation time than the mini-open group for patients with hypervascular tumors. Both mini-open and trans-tubular approaches were intratumorally resectioned. The hyper-vascular tumor had more bleeding at the tumor wound and needed to be compressed to stop bleeding. While pressing, avoiding the spinal cord, nerve root, and other vital structures was necessary. Due to the limited field of vision under the tubular, hemostasis would not be effectively performed before the exposure of important structures such as the spinal cord and nerve root. Compared with mini-open surgery, tubular surgery had stricter criteria on tumor type. For patients with hyper-vascular tumors, the mini-open technique should be given priority. However, the trans-tubular group had less drainage and faster postoperative recovery than the mini-open group, regardless of the tumor’s blood supply. Preoperative arterial embolism or other interventions may be performed to control the bleeding during operation for patients with hyper-vascular tumors [ 12 ].
In this study, the dural sac was more easily injured during the operation. The learning curve for utilizing an emerging technique must be considered when performing trans-tubular surgery. Silva PS et al. analyzed 150 patients with degenerative lumbar disease who underwent MI-TLIF. The most frequent complication was a dural tear (5.32%); the complication rates were 33% and 20.51% for 50% and 90% of learning milestones, respectively. They reported that 90% of the learning curve would be achieved around the 40th case [ 17 ]. Lin J et al. analyzed 62 patients with spinal metastases who underwent mini-open surgery. The operative time decreased gradually with the number of surgical cases increasing and stabilized after the 20th patient [ 13 ]. The complication rate will improve with the growth of this trans-tubular learning curve in the future.
The trans-tubular group had better preoperative ambulatory status than the mini-open group in this study. The poor ambulatory status was often caused by severe compression and poor compensatory ability of the spinal cord. Severe compression was often accompanied by severe deformation of the dural sac and the boundary between the dural sac and the tumor tissue was unclear. Like traditional surgery, mini-open surgery would remove part of the adjacent vertebral lamina to expose the normal dural sac. Then, the boundary of the dural sac could be confirmed. The visibility under the tubular was limited. It was difficult to effectively expose the typical structures of the upper and lower vertebrae and the normal boundary of the dural sac. In this study, the dural sac was more easily injured during the operation.
Lee et al. retrospective analysis of 131 patients with MSCC. The results showed that the local recurrence rate of patients in the en-bloc resection group did not exceed 20%, while the local recurrence rate of patients in the piece-meal resection group increased year by year with the prolongation of the follow-up time and could reach more than 60% at 4 years postoperatively. The difference in the local recurrence rate between the two groups was statistically different [ 18 ]. However, The complications of en-bloc resection were higher. They would affect subsequent adjuvant therapy [ 19 ].
Compared with the mini-open approach, the Trans-tubular approach had disadvantages in intraoperative visualization. On the other hand, the Trans-tubular approach did not achieve circumferential decompression of the dural sac due to the retention of the normal structure of the contralateral side. There was a higher risk of local recurrence and recompression of patients performing the Trans-tubular approach. Effective postoperative systemic therapy, as well as radiotherapy, were even more important for these patients. Radiotherapy was effective as a means to reduce the local recurrence of tumors [ 20 ]. The meta-study results showed a 1-year local recurrence rate of 10% after surgery combined with radiotherapy for MSCC. Surgery combined with radiotherapy was considered a standard treatment option for patients with MSCC. We recommend routine postoperative radiation therapy for patients performing piece-meal resection [ 21 ].
The mini-open approach was only through a small skin incision at the decompression segment. The pedicle screw was inserted through the paravertebral muscle space. The small incision was deficient in visualizing the tumor mass if a mass of tumor tissue formed in the posterior structures of the spine. This approach should better be used in patients with no mass of tumor tissue formed in the posterior structures of the spine. The trans-tubular approach was performed through a unilateral paraspinal muscle space. The application scenarios were more limited for this approach. First, the responsible lesion was only at a single segment, and the lesion was predominantly located unilaterally and can be decompressed by unilateral tumor resection. Second, effective medical systemic therapy or local radiotherapy can be implemented postoperatively. Bilateral or circumferential compression was often accompanied by severe deformation of the dural sac and unclear demarcation from the tumor tissue. In traditional open surgery, it was possible to confirm the boundary of the dural sac and gradually decompress the dural sac by removing part of the adjacent vertebral plate to reveal the normal dural sac. The visual field of the Trans-tubular approach was limited and was more likely to injure the dural sac during the operation. On the other hand, the Trans-tubular approach could not totally remove the posterior structures, and the decompression effect on patients with circumferential compression was not as good as mini-open surgery. Once the tumor recurs, the risk of recompression was higher than that of mini-open surgery, so the patients must receive effective systemic therapy or local radiotherapy after surgery.
It was challenging for patients with local recurrence to identify the tissue structure even with the naked eye due to the hyperplasia of scar tissue. The difficulty would be further increased in the limited field of vision under the tubular. Mini-open surgery had an advantage for patients with recurrent tumors.
There are limitations to the present study:
First, its retrospective and non-randomized nature limited it. However the two groups had no significant difference in baseline data. Selection bias might still affect the results. Second, the relatively small sample size may affect the outcomes available for analysis. A large-scale, prospective, randomized study should be carried out to validate these results. Third, due to missing data of postoperative Hct at 72 h postoperatively, the postoperative Hct in the Gross equation was selected on the first morning after the operation. Patients’ hemodynamics might not be stable at this time, and fluid shifts were not generally complete.
Conclusions
Decompression through Mini-open or Trans-tubular was safe and effective for patients with spinal metastases. The trans-tubular approach was more suitable for patients with hypo-vascular tumors.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Acknowledgements
Not applicable.
Author contribution
Xd S conceived and designed the project. Yp C and Yx P collected and organized the data, analyzed and interpreted the data. Yp C and Xd S wrote the core of the manuscript. Yx P and Yf L coordinated the statistical analyses. C M and B W revised the manuscript. Xd S revised and approved the final version of the manuscript. All authors read and approved the final manuscript.
Funding
Not applicable.
Data Availability
The data supporting this study’s findings are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Declarations
Ethics approval and consent to participate
This study was a retrospective study. There was no follow-up requirement in this study. It was unnecessary to collect blood samples and other samples of the patients, and no additional examination was required. The research ethics committee of Peking University First Hospital approved the study protocol (2022 scientific research 417-001). The research ethics committee of Peking University First Hospital required neither patient approval nor informed consent to review patients’ routine medical records in this study. Researchers would strictly keep the personal information of patients confidential. Identifiable information would not be disclosed to persons other than research members unless permission was obtained from the patient. All research members were required to keep the identity of patients confidential. No patients’ personal information would be disclosed when the research results were published. This study was conducted following the ethical standards in the 1964 Declaration of Helsinki.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Abbreviations
Visual Analogue Scale
American Spinal Injury Association Impairment Scale
American Society of Anesthesiologists,HGB,haemoglobin
Haemoglobin
Haematocrit
Albumin
References
1. Siegel RL Miller KD Fuchs HE Jemal A Cancer statistics, 2022 CA Cancer J Clin 2022 72 1 7 33 10.3322/caac.21708 35020204
2. Henry DH Costa L Goldwasser F Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and Prostate cancer) or Multiple Myeloma J Clin Oncol 2011 29 9 1125 32 10.1200/JCO.2010.31.3304 21343556
3. Rosen LS Gordon D Kaminski M Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with Breast cancer or osteolytic lesions of Multiple Myeloma: a phase III, double-blind, comparative trial Cancer J 2001 7 5 377 87 11693896
4. Patchell RA Tibbs PA Regine WF Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial Lancet 2005 366 9486 643 8 10.1016/S0140-6736(05)66954-1 16112300
5. Finkelstein JA Zaveri G Wai E Vidmar M Kreder H Chow E A population-based study of Surgery for spinal metastases. Survival rates and Complications J Bone Joint Surg Br 2003 85 7 1045 50 10.1302/0301-620X.85B7.14201 14516044
6. Hansen-Algenstaedt N Kwan MK Algenstaedt P Comparison between minimally invasive Surgery and Conventional Open Surgery for patients with spinal Metastasis: a prospective propensity score-matched study Spine (Phila Pa 1976) 2017 42 10 789 97 10.1097/BRS.0000000000001893 27584676
7. Miscusi M Polli FM Forcato S Comparison of minimally invasive Surgery with standard open Surgery for vertebral thoracic metastases causing acute myelopathy in patients with short- or mid-term life expectancy: surgical technique and early clinical results J Neurosurg Spine 2015 22 5 518 25 10.3171/2014.10.SPINE131201 25723122
8. Zhu X Lu J Xu H Comparative study between minimally invasive spine Surgery and traditional open Surgery for patients with spinal Metastasis Spine (Phila Pa 1976) 2021 46 1 62 8 10.1097/BRS.0000000000003690 32925689
9. Zairi F Arikat A Allaoui M Marinho P Assaker R Minimally invasive decompression and stabilization for the management of thoracolumbar spine Metastasis J Neurosurg Spine 2012 17 1 19 23 10.3171/2012.4.SPINE111108 22607222
10. Cui Y Shi X Mi C Wang B Pan Y Lin Y Comparison of minimally invasive tubular Surgery with conventional Surgery in the treatment of Thoracolumbar Metastasis Cancer Manag Res 2021 13 8399 409 10.2147/CMAR.S332985 34795525 PMC8593345
11. Nzokou A Weil AG Shedid D Minimally invasive removal of thoracic and lumbar spinal tumors using a nonexpandable tubular retractor J Neurosurg Spine 2013 19 6 708 15 10.3171/2013.9.SPINE121061 24138063
12. Kato S Hozumi T Takaki Y Yamakawa K Goto T Kondo T Optimal schedule of preoperative embolization for spinal Metastasis Surgery Spine (Phila Pa 1976) 2013 38 22 1964 9 10.1097/BRS.0b013e3182a46576 23917645
13. Lin J Zhu X Tang Q Minimally invasive separation Surgery for the treatment of spinal metastases with small incision and freehand pedicle screw fixation: the surgical learning curve BMC Musculoskelet Disord 2022 23 1 273 10.1186/s12891-022-05191-2 35317753 PMC8939122
14. Gross JB Estimating allowable blood loss: corrected for dilution Anesthesiology 1983 58 3 277 80 10.1097/00000542-198303000-00016 6829965
15. Nadler SB Hidalgo JH Bloch T Prediction of blood volume in normal human adults Surgery 1962 51 2 224 32 21936146
16. Pennington Z Ahmed AK Molina CA Ehresman J Laufer I Sciubba DM Minimally invasive versus conventional spine Surgery for vertebral metastases: a systematic review of the evidence Ann Transl Med 2018 6 6 103 10.21037/atm.2018.01.28 29707552 PMC5900071
17. Silva PS Pereira P Monteiro P Silva PA Vaz R Learning curve and Complications of minimally invasive transforaminal lumbar interbody fusion Neurosurg Focus 2013 35 2 E7 10.3171/2013.5.FOCUS13157 23905958
18. Li H Gasbarrini A Cappuccio M Terzi S Paderni S Mirabile L Boriani S Outcome of excisional surgeries for the patients with spinal metastases Eur Spine J 2009 18 10 1423 30 10.1007/s00586-009-1111-9 19655177 PMC2899386
19. Boriani S Gasbarrini A Bandiera S Ghermandi R Lador R Predictors for Surgical Complications of en bloc resections in the spine: review of 220 cases treated by the same team Eur Spine J 2016 25 3932 41 10.1007/s00586-016-4463-y 26972427
20. Barzilai O Laufer I Robin A Hybrid therapy for metastatic epidural spinal cord Compression: technique for separation Surgery and spine radiosurgery Oper Neurosurg (Hagerstown) 2019 16 3 310 8 10.1093/ons/opy137 29889256 PMC7189205
21. Hu JX Gong YN Jiang XD Jiang L Zhuang HQ Meng N Liu XG Wei F Liu ZJ Local Tumor Control for Metastatic Epidural Spinal Cord Compression Following Separation Surgery with adjuvant CyberKnife stereotactic radiotherapy or image-guided intensity-modulated Radiotherapy World Neurosurg 2020 141 e76 e85 10.1016/j.wneu.2020.04.183 32360927